Search research articles
Contact Us
Filters
Showing results (21-30 of 40) with videos related to
Page
of 4
Sort By:
Mini Reviews in Medicinal Chemistry
|
November 26, 2009
Ligands of diltiazem binding site: an overview of some chemotypes
R Budriesi, P Ioan, E Carosati, et al.
Bioorganic & Medicinal Chemistry
|
March 1, 1995
Synthesis, muscarinic blocking activity and molecular modeling studies of 4-DAMP-related compounds
M Recanatini, V Tumiatti, R Budriesi, et al.
Journal of Medicinal Chemistry
|
September 30, 1994
Design, synthesis, and biological activity of methoctramine-related tetraamines bearing an 11-acetyl-5,11-dihydro-6H-pyrido[2,3-b][1,4] benzodiazepin-6-one moiety: structural requirements for optimum occupancy of muscarinic receptor subtypes as revealed by symmetrical and unsymmetrical polyamines
A Minarini, M L Bolognesi, R Budriesi, et al.
Arzneimittel-Forschung
|
September 1, 1995
Structure-activity relationship studies in the field of calcium antagonists. Xanthone 1,4-dihydropyridines bearing a 2,3-lactone ring
A Rampa, R Budriesi, A Bisi, et al.
Bioorganic & Medicinal Chemistry
|
September 15, 2001
Structure-activity relationships and optimisation of the selective MDR modulator 2-(3,4-dimethoxyphenyl)-5-(9-fluorenylamino)-2-(methylethyl) pentanenitrile and its N-methyl derivative
S Dei, E Teodori, A Garnier-Suillerot, et al.
Journal of Computer-Aided Molecular Design
|
April 1, 1994
Semi-rigid analogues of the calcium antagonist verapamil: a molecular modelling study
M N Romanelli, S Dei, S Scapecchi, et al.
Farmaco (Societa Chimica Italiana : 1989)
|
May 12, 2001
Analogues of polyamine alkaloids and their synthetic advantages
Y Li, K Popaj, M Lochner, et al.
Farmaco (Societa Chimica Italiana : 1989)
|
July 11, 1998
Search for selective antagonists at alpha 1-adrenoreceptors: neutral or negative antagonism?
C Melchiorre, M L Bolognesi, R Budriesi, et al.
Current Medicinal Chemistry
|
June 20, 2012
1,4-Dihydropyridine scaffold in medicinal chemistry, the story so far and perspectives (part 2): action in other targets and antitargets
E Carosati, P Ioan, M Micucci, et al.
Journal of Medicinal Chemistry
|
October 10, 1998
Universal template approach to drug design: polyamines as selective muscarinic receptor antagonists
M L Bolognesi, A Minarini, R Budriesi, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 40) with videos related to
Sort By:
Page
of 4
Mini Reviews in Medicinal Chemistry
|
November 26, 2009
Ligands of diltiazem binding site: an overview of some chemotypes
R Budriesi, P Ioan, E Carosati, et al.
Bioorganic & Medicinal Chemistry
|
March 1, 1995
Synthesis, muscarinic blocking activity and molecular modeling studies of 4-DAMP-related compounds
M Recanatini, V Tumiatti, R Budriesi, et al.
Journal of Medicinal Chemistry
|
September 30, 1994
Design, synthesis, and biological activity of methoctramine-related tetraamines bearing an 11-acetyl-5,11-dihydro-6H-pyrido[2,3-b][1,4] benzodiazepin-6-one moiety: structural requirements for optimum occupancy of muscarinic receptor subtypes as revealed by symmetrical and unsymmetrical polyamines
A Minarini, M L Bolognesi, R Budriesi, et al.
Arzneimittel-Forschung
|
September 1, 1995
Structure-activity relationship studies in the field of calcium antagonists. Xanthone 1,4-dihydropyridines bearing a 2,3-lactone ring
A Rampa, R Budriesi, A Bisi, et al.
Bioorganic & Medicinal Chemistry
|
September 15, 2001
Structure-activity relationships and optimisation of the selective MDR modulator 2-(3,4-dimethoxyphenyl)-5-(9-fluorenylamino)-2-(methylethyl) pentanenitrile and its N-methyl derivative
S Dei, E Teodori, A Garnier-Suillerot, et al.
Journal of Computer-Aided Molecular Design
|
April 1, 1994
Semi-rigid analogues of the calcium antagonist verapamil: a molecular modelling study
M N Romanelli, S Dei, S Scapecchi, et al.
Farmaco (Societa Chimica Italiana : 1989)
|
May 12, 2001
Analogues of polyamine alkaloids and their synthetic advantages
Y Li, K Popaj, M Lochner, et al.
Farmaco (Societa Chimica Italiana : 1989)
|
July 11, 1998
Search for selective antagonists at alpha 1-adrenoreceptors: neutral or negative antagonism?
C Melchiorre, M L Bolognesi, R Budriesi, et al.
Current Medicinal Chemistry
|
June 20, 2012
1,4-Dihydropyridine scaffold in medicinal chemistry, the story so far and perspectives (part 2): action in other targets and antitargets
E Carosati, P Ioan, M Micucci, et al.
Journal of Medicinal Chemistry
|
October 10, 1998
Universal template approach to drug design: polyamines as selective muscarinic receptor antagonists
M L Bolognesi, A Minarini, R Budriesi, et al.
Page
of 4